The 20 Best Neuroendocrine Tumor Doctors Near Me in New Hyde Park, NY

Angela Bennett is a Radiologist practicing medicine in New Hyde Park, New York. Dr. Bennett is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Lung Nodules, Lymphofollicular Hyperplasia, and Caffey Disease. Dr. Bennett is board certified in American Board Of Nuclear Medicine.

Paul Sicuro is a Radiologist practicing medicine in Manhasset, New York. Dr. Sicuro is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Melorheostosis, Melorheostosis with Osteopoikilosis, Osteopenia, and Lung Nodules.

"Matthew J. Weiss, MD, FACS, is deputy physician-in-chief and director of the surgical oncology program at Northwell Cancer Institute. He's a board-certified surgeon specializing in pancreas and liver diseases.With a relentless work ethic and strong desire to help people, Dr. Weiss always knew he wanted to be a doctor. ""I picked a field that allows me to tackle difficult problems and truly make an impact,"" he says.Dr. Weiss completed his residency in general surgery at Johns Hopkins Hospital and was dual fellowship trained in surgical oncology and hepatobiliary surgery at Memorial Sloan-Kettering Cancer Center. He was previously chief of hepatobiliary surgery at Johns Hopkins, where he was also director of the Pancreas and Liver Multidisciplinary Clinics and the complex general surgical oncology fellowship. He also performed the first robotic Whipple at Johns Hopkins University. Joining Northwell in 2019, Dr. Weiss created a multidisciplinary team of surgeons, medical and radiation oncologists, geneticists, and other specialists who collaborate to create unique treatment plans for patients across the health system. ""Every cancer is different, and every patient is different,"" he says. ""Communication among multiple providers is the best way to ensure you're treating the entire person, properly,"" he says. Dr. Weiss's team also works with scientists from Cold Spring Harbor Laboratory and Feinstein Institutes for Medical Research to develop and run groundbreaking clinical trials. An international leader in both liver and pancreas surgery, Dr. Weiss has authored over 250 peer-reviewed publications in the field, and he's currently a professor of surgery and oncology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. ""Understanding both the science of the disease and the technological aspect of surgery is so important,"" he says. Dr. Weiss focuses on using cancer genetics to help find the right surgical approach for patients. When possible, he operates robotically using small incisions for faster healing, so patients don't have to wait as long to receive additional therapies that can improve outcomes. With recent advancements in the field, Dr. Weiss has been able to successfully perform high-risk surgeries that were turned down by other institutions. ""Being a surgeon is a tremendous responsibility, and I don't take it lightly,"" he says. ""I truly and deeply care about my patients and their families-I get to know them as people and am there throughout their entire journey. That's what I'm most proud of as a doctor.""". Dr. Weiss is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Hepatectomy. Dr. Weiss is board certified in American Board Of Surgery.

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Vinciguerra is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Richard Carvajal is an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology.

"Michael Schulder, MD, is the vice chair of neurosurgery at North Shore University Hospital and Long Island Jewish Medical Center. He is also the director of the Brain Tumor Center at the Institute for Neurology and Neurosurgery-which treats more than 600 patients annually-and co-director of the Center for Stereotactic Radiosurgery, where his team offers the latest treatment technologies. His research focuses on improving methods of image guidance for brain tumor surgery, and on new techniques for radiosurgery.""I've always been fascinated by the workings of the brain and how it gives rise to our thoughts, memories and personalities in ways that aren't fully understood,"" Dr. Schulder says. He attended medical school at Columbia University College of Physicians and Surgeons, and completed his residency in neurological surgery at the Albert Einstein College of Medicine. Dr. Schulder also trained in stereotactic neuro-oncology at the University of Florida and the Brigham and Women's Hospital.Dr. Schulder works with neuro-oncologists, radiation oncologists and other neurosurgeons to create evidence-based treatment plans. ""We offer close multidisciplinary collaboration to help avoid delay in seeing patients,"" he says. The team strives to offer minimally invasive treatments as often as possible.With a keen interest in neurosurgical image guidance-the use of real-time images of the brain to make procedures safer and more precise-Dr. Schulder is studying the next generation of intraoperative MRI. He runs a brain tumor clinical trials program, giving his patients ready access to innovative approaches to care. While performing complex neurosurgery is one of the most satisfying parts of Dr. Schulder's job, ""empathizing with patients and their families throughout treatment is equally fulfilling,"" he says.In addition to treating brain tumors, Dr. Schulder performs functional neurosurgery to manage pain conditions like trigeminal neuralgia, and movement disorders including essential tremor and Parkinson's disease. He is the program director of neurosurgical residency training at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Schulder is active in organized neurosurgery, where among other offices he is past president of the World Society for Stereotactic and Functional Neurosurgery, director-at-large of the American Association of Neurological Surgeons, and historian of the American Academy Neurological Surgery.". Dr. Schulder is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Oligodendroglioma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Schulder is board certified in American Board Of Neurological Surgery.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy. Dr. Devoe is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Edward Wolin is an Oncologist practicing medicine in New York, New York. Dr. Wolin is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Carcinoid Syndrome, Liver Embolization, and Endoscopy.

Nitya Raj is an Oncologist practicing medicine in New York, New York. Dr. Raj is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Adrenocortical Carcinoma, Liver Embolization, and Endoscopy. Dr. Raj is currently accepting new patients.

David Zeltsman is a Thoracic Surgeon practicing medicine in New Hyde Park, New York. Dr. Zeltsman is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Pleuropulmonary Blastoma, Lung Cancer, Gastrostomy, and Thymectomy. Dr. Zeltsman is board certified in American Board Of Surgery and American Board Of Thoracic Surgery.

Dr. Kevin Hyman is the chief of Thoracic Surgery at Glen Cove Hospital. He also practices at Long Island Jewish Medical Center, Long Island Jewish Forest Hills and North Shore University Hospital. He has been with Northwell Health since 2007. Dr. Hyman s area of expertise is thoracic surgery, with a special emphasis on minimally invasive thoracic surgery procedures for lung and esophageal cancer, mediastinal tumors, myasthenia gravis, anti-reflux surgery and emphysema surgery. He is also skilled at an array of endobrochial and endoscopic therapies, including stenting and laser therapy.The son of two physicians his father a radiologist, his mother a pediatrician Dr. Hyman has been interested in medicine his entire life. I always loved working with my hands and trying to figure things out, so medicine interested me from early on, he says. He was originally planning on becoming a cardiac surgeon until his father passed away from cancer. He passed during my residency and that was when I realized what I wanted to do. Thoracic surgery has combined that love of working with my hands with the desire to help patients and their loved ones through cancer. Despite the heavy nature of some of the diseases Dr. Hyman treats, if you ask any one of his patients what makes him special, they ll likely say his sense of humor. I can be serious when needed, but I always try to joke around and lighten the mood, he says. Patients appreciate that I can make them laugh in a difficult time. It helps make me approachable. Behind the scenes, Dr. Hyman participates in tumor board meetings with other physicians to examine each patient s case and discuss innovative treatments and techniques. And not only is he dedicated to his patients in the present, he s determined to influence the future of cardiothoracic surgery as well he is an assistant professor of Cardiothoracic Surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and a secretary at Long Island Jewish Medical Center Staff Society, an advocacy group for physicians at the medical center. I try to advocate for physicians as well as patients, he says.Dr. Hyman received his postgraduate medical training in both general and cardiothoracic surgery at New York University Medical Center, followed by a year of specialized fellowship training in advanced minimally invasive thoracic surgery at the Mount Sinai School of Medicine. He is a graduate of Cornell University College of Arts and Sciences and Cornell University Medical College. He is board certified by the American Board of Surgery and American Board of Thoracic Surgery and has been published in numerous peer-reviewed journals, including Surgery, Journal of Thoracic and Cardiovascular Surgery, American Journal of Pathology and Journal of Clinical Immunology and Immunopathology. Dr. Hyman is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Pleuropulmonary Blastoma, Gastrostomy, and Endoscopy. Dr. Hyman is board certified in American Board Of Surgery and American Board Of Thoracic Surgery.

Igor Lobko is a Radiologist and an Interventional Radiologist practicing medicine in New Hyde Park, New York. Dr. Lobko is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Ureterocele, Colorectal Cancer, Familial Colorectal Cancer, Liver Embolization, and Gastrostomy. Dr. Lobko is board certified in American Board Of Radiology/Diagnostic Radiology.

Gilbert Rosenblum is a Gastroenterologist practicing medicine in New Hyde Park, New York. Dr. Rosenblum is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His clinical expertise encompasses Gastrointestinal Bleeding, Opioid Induced Constipation, Pediatric Low-Grade Glioma (pLGG), and Obesity. Dr. Rosenblum is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Gastroenterology.

Rajiv Bansal is an Internal Medicine specialist and a Gastroenterologist practicing medicine in New Hyde Park, New York. Dr. Bansal is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 64 other conditions, according to our data. His clinical expertise encompasses Colitis, Viral Gastroenteritis, Gastric Dysmotility, Gastrectomy, and Endoscopy. Dr. Bansal is board certified in American Board Of Internal Medicine/Gastroenterology.

As Director of Quality and Patient Safety for Medical Oncology at the Monter Cancer Center, Dr. Tony Philip is committed to improving clinical outcomes. Board Certified in Hematology and Medical Oncology, Dr. Philip s clinical practice is solely dedicated to the treatment of patients with gastrointestinal cancers and sarcomas (cancers of the soft tissue and bone). He maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He participates in research focused on improving the care of patients with these diseases. Currently an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Philip completed his Hematology/Oncology fellowship at North Shore-LIJ and his internal medicine residency at Long Island Jewish Medical Center. Dr. Philip earned his MD at University at Buffalo School of Medicine and Biomedical Sciences. He is an active member of the American Society of Clinical Oncology, Connective Tissue Oncology Society, and American College of Physicians. Dr. Philip completed the Northwell Physician Leadership Development Program and the American Society of Clinical Oncology Quality Program. Dr. Philip is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Adult Soft Tissue Sarcoma, and Colorectal Cancer. Dr. Philip is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Savona is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Sepideh Gholami is a Surgical Oncologist practicing medicine in Lake Success, New York. Dr. Gholami is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Pancreatic Cancer, Pancreatic Cancer, Hepatectomy, and Pancreaticoduodenectomy. Dr. Gholami is board certified in American Board Of Surgery and American Board Of Surgery/Complex General Oncology.

"Danielle DePeralta, MD, FACS is double board-certified in surgery and surgical oncology, with dual fellowship training in complex surgical oncology and hepato-pancreato-biliary surgery. She specializes in surgical treatment of diseases of the liver, pancreas, and gastrointestinal tract.Named a Castle Connolly Top Doctor in 2021 and 2022, Dr. DePeralta is a leader in her field and is an active member of the Society of Surgical Oncology, American College of Surgeons and International Hepatopancreatobiliary Association. She is the Northwell Physician Champion for the Canopy Cancer Collective, a multi-center team that focuses on improving care for patients with pancreatic cancer. She is also heavily involved in clinical trials and innovations related to cancer care, including regional therapies that target cancer that has spread but is still localized to the liver or peritoneal cavity. She was instrumental in bringing pressurized intraperitoneal aerosolized chemotherapy (PIPAC)-a treatment that can help those with few options-to New York. Long Island Jewish Medical Center is now one of only three sites in the nation to offer such therapy.Treating some of the most aggressive cancers, Dr. DePeralta knows she's seeing patients at their most vulnerable moments. While focusing on giving them their lives back, she often forms close relationships with her patients. ""I try to treat all of my patients the way that I hope someone would care for my mother, my husband, my son,"" she says.Connecting with patients meaningfully is important to Dr. DePeralta, who has a special interest in the human side of medicine. She studied philosophy in college alongside molecular biology and biochemistry. She also completed a medical ethics fellowship during her surgical residency training at Massachusetts General Hospital/Harvard Medical School. Her training has taken her around the world to Uganda, Panama and India, which has fueled her interest in global health and quality health care for all.Her compassion is also shared by her team, from the care navigators and office staff to the nurses and residents. ""We're very lucky to be so well-supported with a great team that cares a lot about our patients,"" Dr. DePeralta says.Having a team like this serves to strengthen the bonds with her patients, who she learns from each day. ""They teach me that you have to keep trying-keep pushing and it's my job to keep supporting them.It's extremely rewarding to treat someone who was very sick, who you see a year down the road is cancer-free and living a normal life.""". Dr. Deperalta is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Liver Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Deperalta is board certified in American Board Of Surgery and American Board Of Surgery/Complex General Oncology.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Anna Levy DO, is Medical Director of Hepatobiliary Malignancies and the Hepatic Artery Pump Infusion Program, based at the Monter Cancer Center. Board certified in Internal Medicine, Hematology, and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Levy s scope of clinical practice includes liver, bile duct, esophageal, gastric, colon, rectal, and anal malignancies. She focuses on providing compassionate, personalized, and evidence based multidisciplinary care. Dr. Levy earned her medical degree at the Lake Erie College of Osteopathic Medicine. She trained in Internal Medicine at the Christiana Care Health System and completed her fellowship in Medical Oncology and Hematology at Long Island Jewish Medical Center. An active member of the American Society of Clinical Oncology, she is fluent in Russian. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Familial Pancreatic Cancer, Anal Cancer, Pancreaticoduodenectomy, and Bone Marrow Aspiration. Dr. Levy is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.